PlainRecalls
FDA Drug Moderate Class II Terminated

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Reported: June 19, 2024 Initiated: May 31, 2024 #D-0549-2024

Product Description

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Reason for Recall

Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
8 bottles
Distribution
Product was distributed to one medical facility.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA. Recalled by RemedyRepack Inc.. Units affected: 8 bottles.
Why was this product recalled?
Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 19, 2024. Severity: Moderate. Recall number: D-0549-2024.